This Clinical Policy Bulletin addresses qualitative and quantitative polymerase chain reaction (PCR) testing.

Chain Reaction Testing policy. CURRENT POLICY. Per Aetna Clinical Policy Bulletins 0650 Polymerase Chain Reaction Testing, Aetna considers polymerase chain ...

Aetna considers bacterial typing, whole genome sequencing as experimental, investigational, or unproven for assisting in the workup of a potential outbreak by a ...

0650-Polymerase Chain Reaction Testing: Selected Indications. back to top 651-700. 0651-Endovascular Repair of Aortic Aneurysms · 0652-Therapeutic Phlebotomy ...

Medical Clinical Policy Bulletins (CPBs) detail the services and procedures we consider medically necessary, cosmetic, or experimental and unproven.

24 мар. 2022 г. · • This policy is supported by Aetna CPB 0650. PLEASE NOTE: THIS NEW PROCESS MAY RESULT IN A CHANGE IN HOW YOUR PRACTICE IS REIMBURSED FOR ...

Polymerase Chain Reaction Testing: Selected Indications- CPB-0650 · Pool Therapy, Aquatic Therapy or Hydrotherapy- CPB-0174 · Positron Emission Tomography (PET) ...

For more information, see Clinical Policy Bulletin (CPB) 0650: Polymerase Chain Reaction Testing: Selected Indications. Changes to the provider appeal ...

Aetna considers the following medically necessary for the management of vaginitis: Vaginitis testing with nucleic acid amplification or direct DNA probe assays ...

Aetna considers gender reassignment surgery medically necessary when all of the following criteria are met: I. Requirements for mastectomy for female-to-male ...